Literature DB >> 1660868

Secretion of polypeptides related to epidermal growth factor and insulinlike growth factor I by a human teratocarcinoma cell line.

N H Jing1, R Shiurba, H Kitani, H Kawakatsu, Y Tomooka, T Sakakura.   

Abstract

To identify polypeptide growth factors for human teratocarcinoma cells, we studied the malignant ovarian teratoma-derived cell line, PA-1, that grew autonomously in serum-free medium. Medium conditioned by undifferentiated PA-1 cells strongly stimulated proliferation of the mouse mammary tumor cell line, GR 2H6, which is responsive to epidermal growth factor (EGF) and insulinlike growth factor-I (IGF-I). After ammonium sulfate precipitation, PA-1 conditioned medium was analyzed by anion exchange chromatography and bioassay of elution fractions on GR 2H6 cells that were grown in medium deficient in either EGF or insulin. The results demonstrated that PA-1 CM contained factors that can substitute for EGF and IGF-I in stimulating growth of GR 2H6 cells. Western blots of peak mitogenic fractions revealed low molecular weight polypeptides that were immunoreactive with either anti-EGF or anti-IGF-I antibodies. Indirect immunofluorescence staining of PA-1 cells with monoclonal antibodies localized receptors for each growth factor, and binding of human EGF and IGF-I to these cells was quantified by radioreceptor assays. Secretion of factors closely related to EGF and IGF-I by PA-1 cells under serum-free conditions may provide a novel model system to study molecular mechanisms of autocrine growth stimulation in teratocarcinomas.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1660868     DOI: 10.1007/bf02630989

Source DB:  PubMed          Journal:  In Vitro Cell Dev Biol        ISSN: 0883-8364


  43 in total

Review 1.  Autocrine growth factors and tumourigenic transformation.

Authors:  R A Lang; A W Burgess
Journal:  Immunol Today       Date:  1990-07

2.  Neuron-specific enolase as a serum marker for immature teratoma and dysgerminoma.

Authors:  M Kawata; S Sekiya; R Hatakeyama; H Takamizawa
Journal:  Gynecol Oncol       Date:  1989-02       Impact factor: 5.482

3.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

4.  An improved fluorometric assay for DNA.

Authors:  R T Hinegardner
Journal:  Anal Biochem       Date:  1971-01       Impact factor: 3.365

Review 5.  Autocrine growth factors and cancer.

Authors:  M B Sporn; A B Roberts
Journal:  Nature       Date:  1985 Feb 28-Mar 6       Impact factor: 49.962

6.  Human teratocarcinoma cells express functional insulin-like growth factor I receptors.

Authors:  S M Weima; L H Stet; M A van Rooijen; S C van Buul-Offers; E J van Zoelen; S W de Laat; C L Mummery
Journal:  Exp Cell Res       Date:  1989-10       Impact factor: 3.905

7.  Onset of endogenous synthesis of epidermal growth factor in neonatal mice.

Authors:  M Popliker; A Shatz; A Avivi; A Ullrich; J Schlessinger; C G Webb
Journal:  Dev Biol       Date:  1987-01       Impact factor: 3.582

Review 8.  Teratocarcinomas and mammalian embryogenesis.

Authors:  G R Martin
Journal:  Science       Date:  1980-08-15       Impact factor: 47.728

9.  Expression of fibroblast growth factor by F9 teratocarcinoma cells as a function of differentiation.

Authors:  S J Braunhut; L J Gudas; T Kurokawa; J Sasse; P A D'Amore
Journal:  J Cell Biol       Date:  1989-06       Impact factor: 10.539

10.  Expression of multiple heparin-binding growth factor species by murine embryonal carcinoma and embryonic stem cells.

Authors:  J K Heath; G D Paterno; A C Lindon; D R Edwards
Journal:  Development       Date:  1989-09       Impact factor: 6.868

View more
  1 in total

1.  Gene therapy of murine teratocarcinoma: separate functions for insulin-like growth factors I and II in immunogenicity and differentiation.

Authors:  J Trojan; T R Johnson; S D Rudin; B K Blossey; K M Kelley; A Shevelev; F W Abdul-Karim; D D Anthony; M L Tykocinski; J Ilan
Journal:  Proc Natl Acad Sci U S A       Date:  1994-06-21       Impact factor: 11.205

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.